Now on ScienceBlogs: And so, driven on ceaselessly toward new shores
Janet D. Stemwedel (whose nom de blog is Dr. Free-Ride) is an associate professor of philosophy at San Jose State University. Before becoming a philosopher, she earned a Ph.D. in physical chemistry. Email her at dr.freeride@gmail.com.
Widget doesn't work? Here's my giving page. Thanks!
Blog carnivals I enjoy:
Add Adventures in Ethics and Science to your Technorati Favorites!
Category: Academia
At Terra Sigillata, Abel notes that the Director of Duke University's Catholic Center is butting in to researchers' attempts to recruit participants for their research. As it happens, that research involves human sexuality and attitudes toward sex toys. Here's how...
Posted by Janet D. Stemwedel at 6:40 PM • 9 Comments • 0 TrackBacks
Category: Ethical research
A day later than promised, let's kick off our discussion of "Research Rashomon: Lessons from the Cameroon Pre-exposure Prophylaxis Trial Site" (PDF). The case study concerns a clinical trial of whether tenofovir, an antiretroviral drug, could prevent HIV infection. Before...
Posted by Janet D. Stemwedel at 7:24 PM • 2 Comments • 0 TrackBacks
Category: Communication
Almost a month ago, I told you about a pair of new case studies released by The Global Campaign for Microbicides which examine why a pair of pre-exposure prophylaxis (PrEP) clinical trials looking at the effectiveness of antiretrovirals in preventing...
Posted by Janet D. Stemwedel at 11:47 AM • 1 Comments • 0 TrackBacks
Category: Current events
You may have heard that the Obama administration has proposed new rules for federal funding of embryonic stem cell (ESC) research. (The proposed rules are available in draft form through the end of the public comment period; the NIH expects...
Posted by Janet D. Stemwedel at 3:13 PM • 1 Comments • 0 TrackBacks
Category: Communication
Earlier this week, I found out about a pair of new case studies being released by The Global Campaign for Microbicides. These cases examine why a pair of pre-exposure prophylaxis (PrEP) clinical trials looking at the effectiveness of microbicides antiretrovirals...
Posted by Janet D. Stemwedel at 3:14 PM • 2 Comments • 0 TrackBacks
Category: Current events
The Independent reports that drug giant Pfizer has agreed to pay a $75 million settlement nine years after Nigerian parents whose children died in a drug trial brought legal action against the company. It's the details of that drug trial...
Posted by Janet D. Stemwedel at 3:53 PM • 8 Comments • 0 TrackBacks
Category: Current events
DrugMonkey responds to the outgoing Drug Czar's deep concerns about research with illegal drugs conducted with subjects who are addicted to those drugs, those concerns reported in an article in the Washington Examiner. From that article: The federal government is...
Posted by Janet D. Stemwedel at 4:39 PM • 8 Comments • 0 TrackBacks
Category: Doing science for the government
In my last post, I started wading into the question of what kinds of ethical questions arise from clinical trials on "alternative" medical treatments, especially clinical trials supported by the National Center on Complementary and Alternative Medicine (NCCAM). The ethical...
Posted by Janet D. Stemwedel at 9:09 PM • 4 Comments • 0 TrackBacks
Category: Doing science for the government
A little while ago, PalMD put up a post at Whitecoat Underground about the current state of the National Center on Complementary and Alternative Medicine (NCCAM), especially at a moment in history when the federal government is spending loads of...
Posted by Janet D. Stemwedel at 2:25 PM • 6 Comments • 0 TrackBacks
Category: Academic integrity
The headlines bring news of another scientist (this time a physician-scientist) caught committing fraud, rather than science. This story is of interest in part because of the scale of the deception -- not a paper or two, but perhaps dozens...
Posted by Janet D. Stemwedel at 3:45 PM • 7 Comments • 0 TrackBacks
